Postpartum-depression trial using Neuronetics' TMS device begins

08/1/2013 | MassDevice.com (Boston)

Neuronetics has begun patient enrollment in a clinical study to test the use of its NeuroStar transcranial magnetic stimulation, or TMS, system in patients with postpartum depression. The outpatient procedure, which takes 37 minutes, was cleared by the FDA for depression patients who have failed to respond to conventional drug therapy.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ